2016

According to KPMG LLP’s U.S. CEO Outlook 2016, CEOs of life science companies are confident about their prospects for growth in…

The coming year will bring along change for practices. The ending of the ICD-10 grace period will bring rising problems for…

On September 22, 2016, the Centers for Medicare and Medicaid Services (CMS) announced information on premiums and costs for…

The U.S. Department of Justice (DOJ) and the U.S. Securities and Exchange Commission (“SEC”) recently have faced criticism for…

“Usual and customary (U&C) pricing” can be a very confusing term, even to executives of specialty pharmacy companies. The term…

Opioids are under the microscope by a variety of groups, including political and pharmaceutical organizations. Now, adding fuel to…

As announced on Monday, October 17, 2016, by the United States Department of Justice (“DOJ”), the nation’s largest nursing home…

On Friday, October 14, 2016, the Department of Health and Human Services (HHS) finalized its rule on the Medicare Access and CHIP…

A large number of pharmaceutical companies across Europe had until June 30, 2016 to disclose their financial interactions with…

According to Politico, this morning Friday October 14, 2016 the MACRA final rule is being released by HHS. While the final…